INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Smartsheet, Inc. of Class Action Lawsuit and Upcoming Deadlines

Pomerantz LLP filed a securities class action against Smartsheet (NYSE: SMAR) alleging it failed to disclose a $56.25/share Blackstone–Vista acquisition offer that was later raised to $56.50/share. The suit claims Smartsheet repurchased shares at market prices during the June 1, 2024–Sep. 23, 2024 class period, when the average price was $46.45/share, allegedly “artificially deflating” the stock. The merger closed Jan. 22, 2025 at $56.50/share, but the litigation introduces potential downside risk from possible damages and disclosure-related reputational impact.

Analysis

This is mostly a governance/process overhang, not a fundamental equity event. The cash loss, if any, should sit primarily with legacy holders and D&O capacity, so the direct P&L impact is small; the bigger consequence is that boards of software names with takeover optionality will now think twice about using buybacks when there is any credible bid process in the background. That can modestly reduce the effectiveness of capital returns as a support for multiple stability in the broader SaaS complex.

In the near term, any price reaction should be a headline-driven nuisance move that fades unless discovery uncovers sponsor-level knowledge or board minutes that materially strengthen plaintiffs’ case. The real catalyst path is in the filings: if the complaint gets traction around internal timing and disclosure discipline, the settlement range can widen and the insurance market may push higher retentions for future tech deals. Over 6-18 months, that can translate into more cautious repurchase behavior and more conservative transaction pacing in private-equity-sponsored software takeouts.

The contrarian point is that the market may be over-penalizing the sponsor brand and underestimating the structural read-through for other software boards. BX’s economic exposure is de minimis relative to franchise earnings, but future deal process friction is real for any public software company trying to balance buybacks, M&A optionality, and disclosure risk. If anything changes pricing, it will be a slower re-rating of governance quality in takeout-prone names rather than an immediate earnings hit.

Key Decisions for Investors

• No direct trade in SMAR; treat this as a legacy litigation/claims-value item, not an equity-duration catalyst. Only own if you are underwriting settlement optionality, not fundamentals.
• Buy BX weakness of 1-2% or more only if the move is purely headline-driven and no new facts emerge in the complaint; target a 1-3 week fade, stop if sponsor-level emails/board minutes surface.
• Reduce or avoid incremental exposure to public software names with active buybacks and latent M&A optionality for the next 1-3 months; the risk is not cash flow, it is a higher governance discount if similar fact patterns appear.
• Set an alert on litigation filings and any reserve/insurance commentary from D&O carriers over the next 30-90 days; that is the real catalyst for whether this remains nuisance noise or becomes a broader process-compliance theme.